Why the study?
The prognostic value of NT-proBNP in patients with multivessel disease undergoing coronary revascularization remained unclear.
Does preprocedural NT-proBNP level predict adverse cardiovascular outcomes in diabetic patients with multivessel coronary disease undergoing revascularization?
Population
886 consecutive diabetic patients with MVD undergoing coronary revascularization
Comparison
Preprocedural NT-proBNP quartiles
Design
Observational cohort study
Follow-up
Median 4.2 years
Authors
Loading...
NT-proBNP may aid post-revascularization risk stratification in diabetic MVD; leaves open whether it should guide therapy or trials.
Does preprocedural NT-proBNP level predict adverse cardiovascular outcomes in diabetic patients with multivessel coronary disease undergoing revascularization?
Preprocedural NT-proBNP is an independent prognostic marker for adverse outcomes in diabetic patients with multivessel disease undergoing revascularization, providing incremental prognostic value over the SYNTAX II score.
Wang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: